This study reports ten year outcomes of the STICH trial. Comparing CABG to medical therapy groups, the authors note that CABG reduced all cause, cardiovascular, and heart failure hospitalizations. This included time-to-first and recurrent events. This was due to fewer total cardiovascular hospitalizations, the majority due to heart failure.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Heart Failure - Ischemic
CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy: 10-Year Follow-Up of the STICH Trial
September 14, 2019
August 22, 2019
A robust RCT that denies association of nuclear CT-defined myocardial viability and long-term benefit from surgical coronary revascularisation. It is worth following the discussion this manuscript is certain to generate..
June 27, 2019
An interesting small British-led randomized controlled trial on modern imaging of coronary atheroma.
Prophylactic Intra-Aortic Balloon Counterpulsation in High Risk Cardiac Surgery: The PINBALL Pilot Multicentre, Registry-Linked, Randomised, Controlled Feasibility Trial
June 13, 2019
An intresting pilot that was stopped due to underrecruitment. Commendable mortality in high-risk coronary artery bypass grafting.
In Global News: Recommendation to Reclassify Surgical Staplers, Defining Cardiogenic Shock, and Weighing In on E-Cigarettes
June 7, 2019
Patient Care and General Interest A new study looking a dietary protein sources and LDL cholesterol levels calls into question the idea that white meat is more heart healthy than red meat.
May 29, 2019
In this Giants of Cardiothoracic Surgery interview, Marco Nardini speaks with Antonio Maria Calafiore of the Prince Sultan Cardiac Center in Riyadh, Saudi Arabia.
In Global News: Cardiac Regeneration in Pigs, Health Effects of Marijuana Use, and Running to Reduce Aortic Stiffness
May 10, 2019
Patient Care and General Interest
Impact of Cell Therapy on Cardiovascular Outcomes in Patients With Refractory Angina: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
April 1, 2019
A robust meta-analysis of randomized controlled trials on stem cell therapies for refractory angina, offering some encouragement.
March 26, 2019
The investigators published the final analysis of the MOMENTUM 3 trial comparing the fully magnetically levitated centrifugal continuous-flow HeartMate 3 pump to the mechanical-bearing axial continuous-flow HeartMate II pump.
March 4, 2019
An important review in a mainstream periodical read by cardiologist colleagues.